Le traitement du VIH par cellules souches en Thaïlande coûte généralement entre $12,000 / 444,000฿ et $18,000 / 666,000฿. Le coût global dépend du nombre de cellules, de leur origine et du niveau d'accréditation de la clinique. En France, ces interventions avoisinent en moyenne $45,000 / 1,665,000฿. La Thaïlande permet une économie d'environ 67%. Les forfaits incluent souvent le test initial de la charge virale, les perfusions de cellules souches et les consultations spécialisées.
Avis d'expert Bookimed : Privilégier des centres certifiés garantit la vitalité des cellules et une sécurité optimale. La Demarest Clinic à Phuket détient l'accréditation AABB pour la culture cellulaire. Rare, ce niveau de certification égale les standards occidentaux les plus exigeants. Par ailleurs, des experts comme le Dr Pichayanith Sroysuwan à Bangkok proposent des thérapies avancées par cellules NK. Ces protocoles exclusifs offrent une excellente valeur aux patients recherchant un soutien immunitaire systémique avec des perfusions.
| Thaïlande | Turquie | Espagne | |
| Thérapie par cellules souches pour le VIH | de $12,000 / 444,000฿ | de $18,000 / 666,000฿ | de $40,000 / 1,480,000฿ |
Bookimed ne facture pas de frais supplémentaires pour les prix des Thérapie par cellules souches pour le VIH. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Thérapie par cellules souches pour le VIH.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Thérapie par cellules souches pour le VIH et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Thérapie par cellules souches pour le VIH.
Dr. Sitthisak Dhammawiatnukul, MD, ABAARM, specializes in Anti-Aging & Regenerative Medicine and Preventive Medicine. His focus areas include Cell Therapy, Aesthetic Medicine, Men’s Health, Gut Health, Hormone Management, and Detox. He practices at Harmony Life Center (2023–present). He also serves as Medical Advisor at Bio Sky Clinic (2010–present).
Accreditations include the A4M Certificate in Anti-Aging and Regenerative Medicine (2011). He is an ISCT member with specialized certification in mesenchymal stem cells (MSCs). He attended the ISCT Annual Meeting in 2016. He completed the Thai Chelation Therapy Association Workshop, Level 17. He also holds certificates of attendance from A4M, the Thai Society of Cosmetic Dermatology and Surgery, the Thai Association of Cell Therapy, and the American Academy of Anti-Aging and Regenerative Medicine.
Training includes non-surgical MSC therapy for knee rejuvenation. He has additional training in gut health, hormone management, and detox. He earned his MD from Chulalongkorn University and a BSc in Medical Technology from Mahidol University. He also holds a medical training certificate from 2003.
Dr. Pichayanith Sroysuwan, M.D., M.Sc. (Anti-Aging & Regenerative Medicine, 2023–present), is a rehabilitation-trained physician. He specializes in lifestyle, anti-aging, regenerative, and personalized medicine. He practices at Foresta & Morning, Cplus Private Hospital, UMC Wellness, WIH Hospital, and Eden/Wellu.
Accreditations: American Board of Anti-Aging & Regenerative Medicine (ABAARM, 2024) and American Board of Laser Surgery (ABLS Renovia, 2024). Advanced training includes aesthetic dermatology and regenerative medicine (Mae Fah Luang, 2022), practical stem cell therapy (2022), chelation therapy (2023), high laser therapy (2019–2021), NAD+ therapy (certified 2023), and myofascial release (AHG).
Experience: Rehabilitation Medicine residency and medical practice at Srinagarind Hospital, Khon Kaen University (2019–2022). Telemedicine consultant for Raksa/Doctor Anywhere (2020–2022). Contributor to COVID-19 programs ThaiRod and COM COVID (Royal College of Family Physicians). Head of Medicine Delivery Services. Public health educator and moderator.
Dr. Gorpong Koowattanataworn, MD, is board-certified in Anti-Aging & Regenerative Medicine (A4M/ABAARM). He earned his MD from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University. He holds a Master’s in Management in Health and Preventive Medicine from Mahidol University. He also holds a Master’s in Anti-Aging & Regenerative Medicine from Mae Fah Luang University. He has a Diploma in Occupational Medicine from Burapha University. He is certified in Practical Stem Cell Therapy (Thai Association of Cell Therapy) and in Chelation Therapy.
Specialties: anti-aging and regenerative medicine; preventive and lifestyle medicine; aesthetic dermatology; cell and stem-cell therapies (MSCs for knee restoration, exosome/MSC therapies); hormone management and bioidentical HRT; cancer immunotherapy (NK cell boosters); weight management; personalized compounded supplements; gut and immune health; men’s sexual health; chelation therapy.
Thailand offers stem cell therapies for HIV primarily in Bangkok and Phuket at facilities overseen by the Thai Food and Drug Administration. Specialized centers like ID Clinic Bangkok and The Demarest Clinic operate alongside academic hubs like Thammasat University to provide regenerative protocols using mesenchymal stem cells.
Bookimed Expert Insight: While many seekers focus on Bangkok, clinics in Phuket like The Demarest Clinic differentiate themselves by integrating in-house satellite medical laboratories and global researcher networks. This infrastructure allows for real-time protocol updates that smaller medical spas cannot match despite similar marketing claims.
Patient Consensus: Patients emphasize the need to verify Thai FDA approval directly and warn against clinics making unverified success claims. Many advise prioritizing standard antiretroviral therapy while researching experimental options to avoid unsubstantiated medical outcomes.